AGP Picks
View all

Tech Times of New York: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Tech Times of New York.

Press releases published on October 23, 2026

Dr. Melasmin Calcium Stick Introduces  Derma Dream Dr. Melasmin Calcium Balm Inspired by Korean Skincare Practices
Century Aluminum Sets Date for Third Quarter 2026 Earnings Announcement
Key Tronic Corporation Announces First Quarter Reporting Date
SERB Pharmaceuticals Announces Positive Results from the Post-Authorisation Efficacy Study of Idefirix® (imlifidase) Presented at ASN Kidney Week 2026
Kaplan Fox Encourages The Ensign Group, Inc. (NASDAQ: ENSG) Investors with Losses to Contact the Firm Before December 7, 2026
Kaplan Fox Alerts Investors of Duolingo, Inc. (NASDAQ: DUOL) to a Pending Securities Class Action – Deadline is December 7, 2026
Kaplan Fox Alerts Investors of Coastal Financial Corporation (NASDAQ: CCB) to a Pending Securities Class Action – Deadline is December 1, 2026
Bronstein, Gewirtz & Grossman LLC Urges Fluence Energy, Inc Investors to Act: Class Action Filed Alleging Investor Harm
Kaplan Fox Alerts Investors of Alphabet Inc. (NASDAQ: GOOGL, GOOG) to a Pending Securities Class Action – Deadline is December 1, 2026
Carahsoft and Partners Showcase Law Enforcement Solutions at the IACP Annual Conference 2026 in Orlando, FL on Oct. 24 – 27
STEMart Introduces Gel Imaging System Solutions to Support Molecular Biology and Laboratory Research
CBiBank Founder Jiangtao Sun Attends Money20/20 USA 2026 to Discuss Cross-Border Financial Infrastructure Development
ASTS Deadline in 21 Days: AST SpaceMobile, Inc. (ASTS) Securities Fraud Class Action Lawsuit Filed; November 13, 2026, Lead Plaintiff Deadline - Kessler Topaz Meltzer & Check, LLP
NeOnc Breaks Through Key Levels, as Brain-Cancer Stock’s Catalysts Continue
Bronstein, Gewirtz & Grossman LLC Urges AppLovin Corporation Investors to Act: Class Action Filed Alleging Investor Harm
Telesat schedules third quarter 2026 earnings conference call for October 29, 2026
Fortrea und Omico kooperieren zur Förderung der biomarkergestützten Entwicklung von Krebsmedikamenten
Fortrea y Omico colaboran para impulsar el desarrollo de fármacos oncológicos guiado por biomarcadores
Collaboration entre Fortrea et Omico pour faire progresser le développement de médicaments oncologiques basés sur des biomarqueurs
שיתוף פעולה בין Fortrea ל-Omico לקידום פיתוח תרופות אונקולוגיות המבוססות על סמנים ביולוגיים

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Tech Times of New York

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.